Search - tctmd.com

Displaying 281 - 300 of 302

Sort: Relevancy | Date

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

February 07, 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

News Conference News STS 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

February 03, 2022

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

News Conference News STS 2022

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Yael L. Maxwell

February 03, 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

February 03, 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

February 02, 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

February 02, 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

February 02, 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

February 02, 2022

Acute Type A Aortic Dissection Repair Outcomes Didn’t Suffer in Early COVID-19

News Conference News STS 2022

Acute Type A Aortic Dissection Repair Outcomes Didn’t Suffer in Early COVID-19

February 01, 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

February 01, 2022

Multiarterial CABG Still Underused Despite Better Outcomes

News Conference News STS 2022

Multiarterial CABG Still Underused Despite Better Outcomes

Yael L. Maxwell

February 01, 2022

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

News Conference News EACTS 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

Michael O'Riordan

October 19, 2021

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

News Conference News TCT 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Michael O'Riordan

October 21, 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

October 16, 2020

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

News Conference News ESC Heart Failure 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

May 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.